Chinese health care stocks rallied 61 per cent last year with more upside expected in 2021. The pressure, however, will be on drug makers and device manufacturers after massive price cuts.
( read original story …)
Home NEWS Coronavirus in China: 2021 outlook brightens for health care operators, pharmaceutical and device makers after price cuts
ADVERTISEMENT
Categories
Beijing
22°
overcast clouds
humidity: 21%
wind: 1m/s SW
H 22 • L 20
Weather from OpenWeatherMap
Recent Posts
- Chip design software firms climb as US lifts curbs on China exports 03/07/2025
- China’s upstart planemaker hails ‘breakthrough’ in its plan to take on Boeing and Airbus 03/07/2025
- ‘Heart’ of hydropower: China unveils world’s first 500-MW turbine after 4-year testing 03/07/2025
- China’s Debt Problem Is 300% Bigger Than America’s 03/07/2025
- Antitrust enforcer Gail Slater on American innovation: ‘We can win the AI race against the Chinese without becoming like China’ 03/07/2025
- Emirates launches new daily flight to Shenzhen; new A350 deploys on Muscat route 03/07/2025
- The “Amazing Shenzhen” Campaign Invited Indonesian Influencers to explore Shenzhen’s Energy and Innovation 03/07/2025
- How China’s new auto giants left GM, VW and Tesla in the dust 03/07/2025
- US and China’s Aircraft Carriers Show Force in Contested Waters 03/07/2025
- Chip design software firms rise as US lifts curbs on China exports 03/07/2025
- China denies military base ambitions in Pacific Islands 03/07/2025
- How the U.S.-China trade war could leave skies dark on the Fourth of July 03/07/2025